Artificial Intelligence in Drug Development Congress
Oxford Global are delighted to announce the 3rd Annual AI in Drug Development Congress, returning to London on 25 – 26 September this year. The revamped agenda for 2019 features 2 interactive streams addressing the key challenges & opportunities in AI in drug discovery, discovery chemistry and machine learning.
Machine learning technologies are predicted to influence the search for new & advanced pharmaceuticals quicker, cheaper and more effectively. These technologies are becoming increasingly important, but challenges still remain. Do not miss out on attending this event, to stay at the forefront of AI research.
•Kristen Fortney, Founder and CEO, BioAge Labs
•Sameen Desai, Director, Celgene
•Friedrich Rippmann, Director, Merck KGaA
•Bhushan Bonde, Head, UCB
•Arndt Schmitz, Senior Technology Expert, Bayer AG
Forming part of our PharmaTec Event Series, the congress is co-located with the established 17th Annual PharmaIT & Data Congress as well as SmartLabs & Laboratory Informatics Congress and Cyber Security and Data Protection in Pharma & Healthcare Congress.
Over 450 delegates across all events within the series, do not miss out on registering now as spaces are filling up fast.
Go Social: Join our PharmaTec Networking Group on LinkedIn, follow us on Twitter at @PharmaTecSeries and join the conversation using the hashtag #PharmaTec19